EMEA-000635-PIP01-09
Key facts
| Active substance |
Expanded human autologous mesenchymal adult stem cells extracted from adipose tissue (CX-401)
|
| Therapeutic area |
Gastroentology-Hepatology
|
| Decision number |
P/20/2010
|
| PIP number |
EMEA-000635-PIP01-09
|
| Pharmaceutical form(s) |
Suspension for injection
|
| Condition(s) / indication(s) |
|
| Route(s) of administration |
Intralesional use
|
| Contact for public enquiries |
TiGenix S.A.U.
E-mail: info@tigenix.com
Tel: +34 918049264 Fax:+34 918049263 |
| Decision type |
P: decision agreeing on a investigation plan, with or without partial waiver(s) and or deferral(s)
|